Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Study Identifier
M13-765
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
20 - 66 Years
Protocol Summary
This is a study of ABT-126 in the treatment of cognitive impairment associated with schizophrenia (CIAS), a long-term extension study to study M10-855 (NCT01655680).
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 95398
Chino, California, United States, 91710
Status
Not applicable
Location
Site Reference ID/Investigator# 95381
Costa Mesa, California, United States, 92626
Status
Not applicable
Location
Site Reference ID/Investigator# 95400
Escondido, California, United States, 92025
Status
Not applicable
Location
Site Reference ID/Investigator# 95406
Garden Grove, California, United States, 92845
Status
Not applicable
Location
Site Reference ID/Investigator# 95378
National City, California, United States, 91950
Status
Not applicable
Location
Site Reference ID/Investigator# 95390
Norwalk, California, United States, 90650
Status
Not applicable
Showing {first} - {last} of {total} Results